Join
Live feed
·
INSIDERFilingvia Quantisnow
Theseus Pharmaceuticals Inc. logo

SEC Form 4: Dahms Bradford D. bought $10,000 worth of shares (1,502 units at $6.66), increasing direct ownership by 32% to 6,142 units

ByQuantisnow·Wall Street's wire, on your screen.
THRX· Theseus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track THRX (Theseus Pharmaceuticals Inc.) and more on Quantisnow.